DBN1 and Dravet syndrome: Furthermore, neuronal levels of drebrin are reduced in patients with AD [42], Down’s syndrome (DS) [43], and even mild cognitive impairment [44], which is a putative prodromal stage of AD [45], suggesting that drebrin may serve as an important molecular indicator of brain pathophysiology.